Showing results (71-80 of 342) with videos related to
Sort By:
Pageof 35
Clinical Pharmacology and Therapeutics|October 29, 2010
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemiaN Pottier, S W Paugh, C Ding, et al.Clinical Pharmacology and Therapeutics|January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.Lancet (London, England)|July 16, 1999
High incidence of secondary brain tumours after radiotherapy and antimetabolitesM V Relling, J E Rubnitz, G K Rivera, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|July 16, 1999
Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detectionX Cai, M H Woo, M J Edick, et al.Blood|November 9, 2000
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemiaA Gajjar, P L Harrison, J T Sandlund, et al.Blood|September 15, 1996
Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cellsC L Chen, J C Fuscoe, Q Liu, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamilyM V Relling, T Aoyama, F J Gonzalez, et al.Leukemia|November 22, 1997
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignanciesC H Pui, M V Relling, F Lascombes, et al.Gut|March 26, 2003
Pharmacogenomics: marshalling the human genome to individualise drug therapyW E EvansBlut|June 1, 1988
Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensityW E EvansPageof 35